Genetic variants associated with phenytoin-related severe cutaneous adverse reactions

WH Chung, WC Chang, YS Lee, YY Wu, CH Yang… - Jama, 2014 - jamanetwork.com
Importance The antiepileptic drug phenytoin can cause cutaneous adverse reactions,
ranging from maculopapular exanthema to severe cutaneous adverse reactions, which …

CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects

V Franco, E Perucca - Expert opinion on drug metabolism & …, 2015 - Taylor & Francis
Introduction: Phenytoin, a widely prescribed old-generation antiepileptic drug, requires
careful individualization of dosage to compensate for its prominent pharmacokinetic …

HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians

SC Su, CB Chen, WC Chang, CW Wang… - Clinical …, 2019 - Wiley Online Library
To develop a pre‐emptive genetic test that comprises multiple predisposing alleles for the
prevention of phenytoin‐related severe cutaneous adverse reactions (SCARs), three sets of …

Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population

W Tassaneeyakul, N Prabmeechai… - Pharmacogenetics …, 2016 - journals.lww.com
Background Phenytoin is one of the most common causative drugs of several types of
severe cutaneous adverse reactions (SCAR) such as Stevens–Johnson syndrome (SJS) …

Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions

K Yampayon, C Sukasem, C Limwongse… - European Journal of …, 2017 - Springer
Purpose The purpose of this study was to investigate the association of genetic factors
including variants in HLA-B and CYP2C genes and non-genetic factors with phenotype …

Genetic predisposition of life-threatening antiepileptic-induced skin reactions

WH Chung, SI Hung, YT Chen - Expert Opinion on Drug Safety, 2010 - Taylor & Francis
Importance of the field: Recent advances in pharmacogenetic studies have uncovered
increasingly more genes that predispose individuals to adverse drug reactions. Aromatic …

A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients

M Tohkin, N Kaniwa, Y Saito, E Sugiyama… - The …, 2013 - nature.com
Stevens–Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are severe,
cutaneous adverse drug reactions that are rare but life threatening. Genetic biomarkers for …

Identification of a null allele of CYP2C9 in an African–American exhibiting toxicity to phenytoin

RS Kidd, TB Curry, S Gallagher, T Edeki… - Pharmacogenetics …, 2001 - journals.lww.com
Abstract Cytochrome P450 (CYP) 2C9 is the principal enzyme responsible for the
metabolism of numerous clinically important drugs. Two polymorphic alleles CYP2C9* 2 and …

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing

KE Caudle, AE Rettie, M Whirl‐Carrillo… - Clinical …, 2014 - Wiley Online Library
Phenytoin is a widely used antiepileptic drug with a narrow therapeutic index and large
interpatient variability, partly due to genetic variations in the gene encoding cytochrome …

Genetic polymorphism of cytochrome P 450 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions

AY Lee, MJ Kim, WY Chey, J Choi, BG Kim - European journal of clinical …, 2004 - Springer
Background Apart from allergic mechanisms, a lack or mutation of metabolic enzymes may
cause adverse drug reactions. Patch testing has rarely been useful in cutaneous adverse …